203 related articles for article (PubMed ID: 6695525)
1. [Effect of different types of treatment on the levels of steroid hormone receptors in breast tumors].
Koposova TL; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Gershteĭn ES
Vopr Onkol; 1984; 30(1):37-41. PubMed ID: 6695525
[TBL] [Abstract][Full Text] [Related]
2. Trepanobiopsy as a tool for the study of the influence of presurgical treatment on the steroid receptor status of advanced breast cancer.
Bassalyk LS; Koposova TL; Muravyeva NI; Smirnova KD; Kuzmina ZV; Gershtein ES; Letyagin VP
Neoplasma; 1986; 33(2):245-50. PubMed ID: 3713927
[TBL] [Abstract][Full Text] [Related]
3. [Cytoplasmic steroid hormone receptors in primary breast tumors].
Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic importance of determining steroid hormone receptors in breast tumors].
Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Gershteĭn ES
Vopr Onkol; 1982; 28(5):82-8. PubMed ID: 7090287
[TBL] [Abstract][Full Text] [Related]
5. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
[TBL] [Abstract][Full Text] [Related]
6. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
Makhova EE; Gershteĭn ES; Smirnova KD; Murav'eva NI; Kuz'mina ZV
Vopr Onkol; 1984; 30(12):36-40. PubMed ID: 6516272
[TBL] [Abstract][Full Text] [Related]
7. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
Osborne CK; McGuire WL
Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine].
Bassalyk LS; Korotkova TV; Prorokov VV; Murav'eva NI; Smirnova KD
Vopr Onkol; 1987; 33(9):43-6. PubMed ID: 3660756
[TBL] [Abstract][Full Text] [Related]
9. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
[TBL] [Abstract][Full Text] [Related]
11. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer].
Ermilova VD; Koposova TL; Murav'ëva NI; Kuz'mina ZV
Vopr Onkol; 1985; 31(12):69-73. PubMed ID: 4082510
[TBL] [Abstract][Full Text] [Related]
12. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
14. Blood hemoglobin level and treatment outcome of early breast cancer.
Henke M; Sindlinger F; Ikenberg H; Gerds T; Schumacher M
Strahlenther Onkol; 2004 Jan; 180(1):45-51. PubMed ID: 14704844
[TBL] [Abstract][Full Text] [Related]
15. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
16. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
17. [Steroid hormone receptors in malignant tumors of the large intestine].
Korotkova TV; Bassalyk LS; Knysh VI; Prorokov VV
Vopr Onkol; 1984; 30(9):64-8. PubMed ID: 6495697
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
20. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
